Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and
ChemR23 to regulate inflammation.
Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN.
J Immunol. 2007 Mar 15;178(6):3912-7.
PMID: 17339491
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.
Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN.
J Exp Med. 2005 Mar 7;201(5):713-22.
PMID: 15753205
oi:10.1084/jem.20042031
March 7, 2005
Boston, MA - The anti-inflammatory effect of fish oils appears to be due to a powerful anti-inflammatory compound called resolvin (resolution-phase interaction product) E1, which is produced from eicosapentaenoic acid (EPA), Dr Makoto Arita (Brigham and Women's Hospital and Harvard Medical School, Boston, MA) and colleagues report in the March 7, 2005 issue of the Journal of Experimental Medicine [1]. Arita writes, "At nanomolar levels, resolvin E1 dramatically reduced dermal inflammation, peritonitis, dendritic cell migration, and interleukin (IL)-12 production.